-
1
-
-
0023601716
-
Serum levels of interferons in patients with systemic lupus erythematosus
-
Kim T, Kanayama Y, Negoro N et al. Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 70: 562-569.
-
(1987)
Clin Exp Immunol
, vol.70
, pp. 562-569
-
-
Kim, T.1
Kanayama, Y.2
Negoro, N.3
-
2
-
-
0020049392
-
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis
-
Hooks JJ, Jordan GW, Cupps T et al. Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum 1982; 25: 396-100.
-
(1982)
Arthritis Rheum
, vol.25
, pp. 396-1100
-
-
Hooks, J.J.1
Jordan, G.W.2
Cupps, T.3
-
3
-
-
0018775078
-
Immune interferon in the circulation of patients with autoimmune disease
-
Hooks JJ, Moutsopoulos HM, Geis SA et al. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979; 301: 5-8.
-
(1979)
N Engl J Med
, vol.301
, pp. 5-8
-
-
Hooks, J.J.1
Moutsopoulos, H.M.2
Geis, S.A.3
-
4
-
-
0020026322
-
Serum interferon levels in patients with systemic lupus erythematosus
-
Ytterberg SR, Schnitzer TJ. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 1982; 25: 401-406.
-
(1982)
Arthritis Rheum
, vol.25
, pp. 401-406
-
-
Ytterberg, S.R.1
Schnitzer, T.J.2
-
5
-
-
0032238891
-
Association of Interferon γ, tumor necrosis factor α and interleukin 6 serum levels with systemic lupus erythematosus activity
-
Robak E, Sysa-Jedrzejewska A, Dziankowska B et al. Association of Interferon γ, tumor necrosis factor α and interleukin 6 serum levels with systemic lupus erythematosus activity. Arch Immunol Ther Exp 1998; 46: 375-80.
-
(1998)
Arch Immunol Ther Exp
, vol.46
, pp. 375-380
-
-
Robak, E.1
Sysa-Jedrzejewska, A.2
Dziankowska, B.3
-
6
-
-
0030742301
-
Hyperinducible expression of the interferon-gamma (IFN-gamma) gene and its suppression in systemic lupus erythematosus (SLE)
-
Gerez L, Shkolnik T, Hirschmann O et al. Hyperinducible expression of the interferon-gamma (IFN-gamma) gene and its suppression in systemic lupus erythematosus (SLE). Clin Exp Immunol 1997; 109: 296-303.
-
(1997)
Clin Exp Immunol
, vol.109
, pp. 296-303
-
-
Gerez, L.1
Shkolnik, T.2
Hirschmann, O.3
-
7
-
-
0032939098
-
Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
-
Viallard JF, Pellegrin JL, Ranchin V et al. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1999; 115: 189-195.
-
(1999)
Clin Exp Immunol
, vol.115
, pp. 189-195
-
-
Viallard, J.F.1
Pellegrin, J.L.2
Ranchin, V.3
-
8
-
-
0019971912
-
Structure of the human immune interferon gene
-
Gray PW, Goeddel DV. Structure of the human immune interferon gene. Nature 1982; 298: 859-663.
-
(1982)
Nature
, vol.298
, pp. 859-1663
-
-
Gray, P.W.1
Goeddel, D.V.2
-
9
-
-
0032969945
-
In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene
-
Pravica V, Asderakis A, Perrey C et al. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999; 26: 1-3.
-
(1999)
Eur J Immunogenet
, vol.26
, pp. 1-3
-
-
Pravica, V.1
Asderakis, A.2
Perrey, C.3
-
10
-
-
4243900858
-
A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families
-
Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Nat Acad Sci USA 1998; 95: 14875-14879.
-
(1998)
Proc Nat Acad Sci USA
, vol.95
, pp. 14875-14879
-
-
Gaffney, P.M.1
Kearns, G.M.2
Shark, K.B.3
-
11
-
-
0033023228
-
Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus
-
Tanaka Y, Nakashima H, Hisano C et al. Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus. Immunogenet 1999; 49: 266-271.
-
(1999)
Immunogenet
, vol.49
, pp. 266-271
-
-
Tanaka, Y.1
Nakashima, H.2
Hisano, C.3
-
12
-
-
0030702821
-
Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis
-
Seery JP, Carroll JM, Cattell V, Watt FM. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J Exp Med 1997; 186: 1451-1459.
-
(1997)
J Exp Med
, vol.186
, pp. 1451-1459
-
-
Seery, J.P.1
Carroll, J.M.2
Cattell, V.3
Watt, F.M.4
-
13
-
-
0024511891
-
The abnormal T lymphocytes in lpr mice transcribe interferon-γ and tumor necrosis factor-a genes spontaneously in vivo
-
Murray L, Martens C. The abnormal T lymphocytes in lpr mice transcribe interferon-γ and tumor necrosis factor-a genes spontaneously in vivo. Eur J Immunol 1989; 19: 563-565.
-
(1989)
Eur J Immunol
, vol.19
, pp. 563-565
-
-
Murray, L.1
Martens, C.2
-
14
-
-
0031155269
-
IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice
-
Haas C, Ryffel B, Le Hir M. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J Immunol 1997; 158: 5484-5491.
-
(1997)
J Immunol
, vol.158
, pp. 5484-5491
-
-
Haas, C.1
Ryffel, B.2
Le Hir, M.3
-
15
-
-
0031831859
-
IFN-γ receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Faslpr Mice
-
Schwarting A, Wada T, Kinoshitia K, Tesch G, Kelley VR. IFN-γ receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Faslpr Mice. J Immunol 1998; 161: 494-503.
-
(1998)
J Immunol
, vol.161
, pp. 494-503
-
-
Schwarting, A.1
Wada, T.2
Kinoshitia, K.3
Tesch, G.4
Kelley, V.R.5
-
16
-
-
0030953632
-
Roles of interferon-gamma and interleukin-4 in murine lupus
-
Peng SL, Moslehi J, Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest 1997; 99: 1936-1946.
-
(1997)
J Clin Invest
, vol.99
, pp. 1936-1946
-
-
Peng, S.L.1
Moslehi, J.2
Craft, J.3
-
17
-
-
0032518439
-
Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice
-
Balomenos D, Rumold R, Theofilopoulos AN. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest 1998; 101: 364-371.
-
(1998)
J Clin Invest
, vol.101
, pp. 364-371
-
-
Balomenos, D.1
Rumold, R.2
Theofilopoulos, A.N.3
-
18
-
-
0032522778
-
IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB X NZW)F1 mice
-
Haas C, Ryffel B, Le Hir M, IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB X NZW)F1 mice. J Immunol 1998; 160: 3713-3718.
-
(1998)
J Immunol
, vol.160
, pp. 3713-3718
-
-
Haas, C.1
Ryffel, B.2
Le Hir, M.3
-
19
-
-
0033976316
-
Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice
-
Nicoletti F, Di Marco R, Zaccone P et al. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice. Eur J Immunol 2000; 30: 438-447.
-
(2000)
Eur J Immunol
, vol.30
, pp. 438-447
-
-
Nicoletti, F.1
Di Marco, R.2
Zaccone, P.3
-
20
-
-
0033942181
-
Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc
-
Lawson BR, Prud'homme GJ, Chang Y et al. Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. J Clin Invest 2000; 106: 207-215.
-
(2000)
J Clin Invest
, vol.106
, pp. 207-215
-
-
Lawson, B.R.1
Prud'homme, G.J.2
Chang, Y.3
-
21
-
-
0023571873
-
In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon
-
Jacob CO, van der Meide PH, McDevitt HO. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med 1987; 166: 798-806.
-
(1987)
J Exp Med
, vol.166
, pp. 798-806
-
-
Jacob, C.O.1
Van Der Meide, P.H.2
McDevitt, H.O.3
-
22
-
-
0028963222
-
Experimental therapy of systemic lupus erythematosus: The treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis
-
Ozmen L, Roman D, Fountoulakis M et al. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis. Eur J Immunol 1995; 25: 6-12.
-
(1995)
Eur J Immunol
, vol.25
, pp. 6-12
-
-
Ozmen, L.1
Roman, D.2
Fountoulakis, M.3
-
23
-
-
0345196597
-
Measures of disease activity, damage, and health status: The Hopkins Lupus Cohort experience
-
Petri M, Barr SG, Zonana-Nach A, Magder L. Measures of disease activity, damage, and health status: the Hopkins Lupus Cohort experience. J Rheumatol 1999; 26: 502-503.
-
(1999)
J Rheumatol
, vol.26
, pp. 502-503
-
-
Petri, M.1
Barr, S.G.2
Zonana-Nach, A.3
Magder, L.4
-
24
-
-
0034087160
-
Hopkins Lupus Cohort. 1999 update
-
Petri M. Hopkins Lupus Cohort. 1999 update. Rheum Dis Clin N Am 2000; 26: 199-213.
-
(2000)
Rheum Dis Clin N Am
, vol.26
, pp. 199-213
-
-
Petri, M.1
|